Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Pierantonelli

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Transplantation|October 10, 2018
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASHIrene Pierantonelli, Gianluca Svegliati-Baroni
Current Drug Targets|January 14, 2016
Current Targets for Primary Sclerosing CholangitisIrene Pierantonelli, Antonio Benedetti, Marco Marzioni
Hepatobiliary Surgery and Nutrition|February 27, 2014
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cellsLuca Maroni, Irene Pierantonelli, Antonio Benedetti, et al.
Annals of Translational Medicine|October 22, 2014
The significance of genetics for cholangiocarcinoma developmentLuca Maroni, Irene Pierantonelli, Jesus M Banales, et al.
Free Radical Biology & Medicine|June 2, 2019
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver diseaseGianluca Svegliati-Baroni, Irene Pierantonelli, Pierangelo Torquato, et al.
Journal of Hepatology|July 13, 2010
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiationMarco Marzioni, Stefania Saccomanno, Cinzia Candelaresi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2012
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndromeGiovanna Fattovich, Gianluca Svegliati Baroni, Michela Pasino, et al.
Gut|October 23, 2010
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis CGianluca Svegliati-Baroni, Graziella Faraci, Luca Fabris, et al.
Journal of Hepatology|December 5, 2012
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitisMarco Marzioni, Stefania Saccomanno, Laura Agostinelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activationIrene Pierantonelli, Gessica Lioci, Fabio Gurrado, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Transplantation|October 10, 2018
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASHIrene Pierantonelli, Gianluca Svegliati-Baroni
Current Drug Targets|January 14, 2016
Current Targets for Primary Sclerosing CholangitisIrene Pierantonelli, Antonio Benedetti, Marco Marzioni
Hepatobiliary Surgery and Nutrition|February 27, 2014
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cellsLuca Maroni, Irene Pierantonelli, Antonio Benedetti, et al.
Annals of Translational Medicine|October 22, 2014
The significance of genetics for cholangiocarcinoma developmentLuca Maroni, Irene Pierantonelli, Jesus M Banales, et al.
Free Radical Biology & Medicine|June 2, 2019
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver diseaseGianluca Svegliati-Baroni, Irene Pierantonelli, Pierangelo Torquato, et al.
Journal of Hepatology|July 13, 2010
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiationMarco Marzioni, Stefania Saccomanno, Cinzia Candelaresi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2012
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndromeGiovanna Fattovich, Gianluca Svegliati Baroni, Michela Pasino, et al.
Gut|October 23, 2010
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis CGianluca Svegliati-Baroni, Graziella Faraci, Luca Fabris, et al.
Journal of Hepatology|December 5, 2012
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitisMarco Marzioni, Stefania Saccomanno, Laura Agostinelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2020
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activationIrene Pierantonelli, Gessica Lioci, Fabio Gurrado, et al.
Pageof 2